| CASE REPORT |
|
| Year : 2016 | Volume
: 35
| Issue : 3 | Page : 167-172 |
|
|
Ayurvedic approach in the management of spinocerebellar ataxia-2
Sarvesh Kumar Singh1, Kshipra Rajoria2
1 Department of Panchkarma, National Institute of Ayurveda, Jaipur, Rajasthan, India
2 Department of Panchkarma, M.J.F. Ayurvedic College and Hospital, Jaipur, Rajasthan, India
Correspondence Address:
Sarvesh Kumar Singh
C109, Gol Market, Jawahar Nagar, Jaipur, Rajasthan
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0257-7941.179873
|
|
|
Spinocerebellar ataxia -2 is a progressive, degenerative genetic disease caused by an expanded (CAG) trinucleotide repetition on the chromosome 12 resulting in production of an abnormal protein called ataxin-2. There is no known effective management or cure in biomedicine for this genetic disease. In the present study a case of SCA2 that was treated with Ayurvedic intervention is reported. Ayurvedic treatments in this case were directed towards alleviating symptoms and to reduce severe disability due to progressive nature of disease. A 42 year old male patient was diagnosed for Vāta vyādhi (group of various neurological disorders) and was- treated with Śālisastika pinda svedana (sudation with bolus of medicated cooked rice) for 30 days-, Śirobasti(sudation of head with the help of a cap on head) with Aśvagandhā taila for 45 days and Balaādi ksiāra basti (enema with medicated milk) with Aśvagandhā taila anuvaāsana(enema with oil) for 30 days in Karma basti krama(30 days regime of purification and oleation enema) along with a combination of Ayurvedic oral drugs which consisted of Brahadvaātacintaāmanirasa – 125 mg, Vasantaāmaltiā rasa- 125 mg, Daśamūla kvātha- 40 ml, Aśvagandhā cūrṃa(powder of Withania somnifera DUNAL)- 3g, Amrtaā cūrṃa (powder of Tinospora cordifolia Willd.)- 500 mg, Muktāśukti pisti – 500 mg, Yogaraāja Guggulu – 500 mg twice a day for 2 months. Patient's condition was assessed on the Scale for Assessment and Rating of Ataxia (SARA). Before treatment, mean SARA score was 35. This reduced to 15 after treatment. Good relief in dysarthria, fasciculation, heaviness in eye, blurred vision, axial tremor; constipation and quality of life were observed in this case. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
